Forecast: Trachea, Bronchus or Lung Malignant Neoplasms Mortality in the US

As of 2023, the mortality rate for trachea, bronchus, or lung malignant neoplasms stood at approximately 67.20 thousand male deaths. Forecast data from 2024 to 2028 shows a continuous decline, from 65.69 to 58.8 thousand male deaths, indicating an encouraging downward trend. Year-on-year percentage decreases are approximately -2.66% each year. The compound annual growth rate (CAGR) over the five-year period is about -2.8%, reflecting a positive trend in mortality reduction.

Looking forward, factors to monitor include advancements in medical treatments, changes in smoking rates, and improvements in early detection and prevention strategies, which could accelerate this declining trend.